CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Purple Biotech Ltd   (PPBT)
Other Ticker:  
 

Cumulative Purple Biotech Ltd 's Leverage Ratio for Trailing Twelve Months Period

PPBT's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

PPBT Leverage Ratio for Trailing Twelve Months Period

 (Dec 31 2022)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Equity Growth -27.66 % -27.66 % -27.66 % -27.66 % -18.36 %
Y / Y Total Liabilities Growth 38.61 % 38.61 % 38.61 % 38.61 % 25.7 %
Leverage Ratio for Trailing Twelve Months Period 0.15 0.13 0.11 0.09 0.08
Total Ranking # 413 # # # # 224
Seq. Equity Growth 0 % 0 % 0 % -27.66 % 0 %
Seq. Total Liabilities Growth 0 % 0 % 0 % 38.61 % 0 %

PPBT Segments >> More on PPBT Financial Strength Comparisons >> See PPBT Balance Sheets

Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2022
On the trailing twelve months basis Despite debt repayement of 0% in IV. Quarter, Leverage Ratio for Trailing Twelve Months Period improved to 0.15, below Purple Biotech Ltd 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 123 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Purple Biotech Ltd . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are PPBT's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 124
Sector # 199
S&P 500 # 384


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.38 0.2 0.05
(Jun 30 2019)   (Dec 31 2020)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2022, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Lexicon Pharmaceuticals Inc   0.41 
Biolinerx Ltd   0.41 
Beigene Ltd   0.41 
Zosano Pharma Corporation  0.40 
Opko Health Inc   0.40 
Elite Pharmaceuticals Inc.  0.40 
Unicycive Therapeutics Inc   0.40 
Nucana Plc  0.39 
Ligand Pharmaceuticals Incorporated  0.39 
Bicycle Therapeutics Plc  0.39 
Acadia Pharmaceuticals Inc   0.39 
Histogen Inc   0.39 
Cue Biopharma Inc   0.39 
Biomarin Pharmaceutical Inc  0.39 
Imunon Inc   0.38 
Nurix Therapeutics Inc   0.38 
Actinium Pharmaceuticals Inc   0.38 
Ampio Pharmaceuticals inc   0.37 
Oncolytics Biotech Inc   0.37 
Arbutus Biopharma Corp  0.36 
Aptinyx Inc   0.36 
Tiziana Life Sciences Ltd  0.35 
Kintara Therapeutics Inc   0.35 
Aeglea Biotherapeutics Inc   0.35 
Neubase Therapeutics inc   0.35 
Vyne Therapeutics Inc   0.34 
Geovax Labs Inc   0.33 
Cingulate Inc   0.33 
Pds Biotechnology Corp  0.33 
I mab  0.33 




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071